Psoriatic Arthritis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Psoriatic Arthritis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • March 2019 •
  • 184 pages •
  • Report ID: 5767809 •
  • Format: PDF
Psoriatic Arthritis Therapeutics Market - Overview

This reportanalyses the global psoriatic arthritis therapeutics market for the period between 2018 and 2026.An in-depth and unbiased market assessment has been made, which offers readers an in-depth and accurate analysis.

Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in research & development, manufacture, and marketing of products prescribed in the treatment of psoriatic arthritis.

The global psoriatic arthritis therapeutics market has been studied for the forecast period from 2018 to 2026.For research, 2017 has been considered as the base year and 2016 as the historical year.

The global psoriatic arthritis therapeutics market report comprises an elaborate executive summary that provides overall information about various segments of the market.The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global psoriatic arthritis therapeutics market for 2017.

The report also provides detailed company profiles of emerging market players operating in the global psoriatic arthritis therapeutics market.

The market overview section comprises impact factors such as key market dynamics, including drivers, restraints, and opportunities, affecting the global psoriatic arthritis therapeutics market.These factors are likely to aid stakeholders establish a strong foothold in the global psoriatic arthritis therapeutics market.

Furthermore, the market overview section comprises key industry events, pipeline analysis, key mergers & acquisitions across the industry, epidemiology analysis of the psoriatic arthritis, product portfolio overview of leading players, and market attractiveness analysis in the global psoriatic arthritis therapeutics market. The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.

Scope
The global psoriatic arthritis therapeutics market has been segmented based on drug class, route of administration, distribution channel, and region.In terms of drug class, the global market has been classified into TNF inhibitors, interleukin inhibitors, PDE4 inhibitors, and others.

Based on route of administration, the global market has been segregated into oral, parenteral, and topical. In terms of distribution channel, the global psoriatic arthritis therapeutics market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies.

In terms of region, the global psoriatic arthritis therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, quantitative analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, and Australia & New Zealand has also been provided in the report. A detailed qualitative analysis of factors responsible for driving and restraining the global market in various regions has been provided in this section.

The report provides a detailed outline/blueprint of the global psoriatic arthritis therapeutics market, which is expected to assist new companies establish their presence and companies to expand their share in the market. The report concludes with the company profiles section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments of key players.

Competitive landscape

Major players operating in the global psoriatic arthritis therapeutics market include AbbVie, Inc., Janssen Biotech, Inc., Novartis AG, Amgen, Inc., Celgene Corporation, Pfizer, Inc., Eli Lilly and Company, UCB, Inc., Biogen Inc., and Bristol-Myers and Squibb Company.

The global psoriatic arthritis therapeutics market has been segmented into:

Global Psoriatic Arthritis Therapeutics Market, by Drug Class
TNF Inhibitors
Interleukin Inhibitors
PDE4 Inhibitors
Others

Global Psoriatic Arthritis Therapeutics Market, by Route of Administration
Oral
Parenteral
Topical

Global Psoriatic Arthritis Therapeutics Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Psoriatic Arthritis Therapeutics Market, by Region
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa